A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Clinical trial NCT01582815 · COMPLETED

Trial details

NCT number: NCT01582815
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2012-09-01
Primary completion: 2013-11-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.